Mode
Text Size
Log in / Sign up

Phoenix Sepsis Criteria outperforms IPSCC criteria for pediatric in-hospital mortality risk stratificationNew criteria improve risk prediction for children with sepsis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that PSC demonstrates superior prognostic accuracy for mortality compared to IPSCC in pediatric patients.

This meta-analysis evaluates the diagnostic performance of the Phoenix Sepsis Criteria (PSC) compared to the International Pediatric Sepsis Consensus Conference (IPSCC) criteria for identifying in-hospital mortality in children with suspected infection. The analysis included 15 studies and 16 cohorts involving 2,601,038 encounters in hospital settings.

The meta-analysis found that the PSC demonstrated a sensitivity of 0.77 (95% CI, 0.67-0.85) and a specificity of 0.73 (95% CI, 0.51-0.87). The PSC showed an area under the curve (AUC) of 0.81, which was higher than the IPSCC AUC of 0.71. The difference in AUC between PSC and IPSCC was 0.10 (95% CI, 0.04-0.19). The PSC diagnostic odds ratio was 9.2 (95% CI, 5.1-16.8).

Authors noted that performance varies by setting, specifically noting a difference in PSC specificity between the ICU (0.48) and the ED (0.99). The PSC is intended for prognostic risk stratification rather than frontline early sepsis screening. These findings suggest the PSC provides superior prognostic accuracy for mortality compared to IPSCC, though clinical application should consider the specific hospital setting.

How this fits prior evidence

This meta-analysis addresses a gap in pediatric sepsis risk stratification tools. While previous coverage noted that evidence for immunomodulatory treatments in sepsis is currently hypothesis-generating and direct evidence is scarce, this meta-analysis provides specific data on the diagnostic accuracy of the Phoenix Sepsis Criteria (PSC) compared to IPSCC. The finding that PSC outperforms IPSCC in AUC (0.81 vs 0.71) provides a specific tool for risk stratification in pediatric populations.

When a child develops sepsis, a severe and life-threatening infection, every second counts. Doctors need reliable ways to identify which patients are at the highest risk of death so they can provide the most intensive care. A large review of over 2.6 million hospital encounters looked at how well different sets of rules predict these outcomes.

The study compared the Phoenix Sepsis Criteria (PSC) against the older International Pediatric Sepsis Consensus Conference (IPSCC) rules. The results showed that the PSC was more accurate at predicting mortality. Specifically, the PSC had a higher area under the curve, which is a measure of how well a test distinguishes between different outcomes, compared to the older method.

While the PSC is a strong tool for figuring out a child's risk level, it is not meant to be the first tool used to catch sepsis early. Its strength lies in predicting the severity of the illness once it is already identified. However, the study did note that how well the system works can change depending on where the child is being treated, such as in the emergency room versus the intensive care unit.

What this means for you:
The Phoenix Sepsis Criteria provides more accurate risk predictions for children with sepsis than older methods.

Common questions

What is the Phoenix Sepsis Criteria (PSC)?

The Phoenix Sepsis Criteria (PSC) is a set of rules used by doctors to predict the risk of death in children with sepsis. In this study, it was found to have a higher area under the curve (0.81) than the older IPSCC criteria (0.71), making it a more accurate tool for risk stratification.

Is this tool used to catch sepsis early?

No, the PSC is not intended for frontline early sepsis screening. Instead, it is used for prognostic risk stratification. This means it helps doctors understand the severity of the illness and the risk of death once a child is already identified as having a suspected infection.

How does the tool perform in different hospital areas?

The accuracy of the tool can vary depending on the setting. For example, the study showed a significant difference in specificity between the emergency department (0.99) and the intensive care unit (0.48). You should talk to a doctor about how these tools are used in specific clinical settings.

Study Details

Study typeMeta analysis
EvidenceLevel 1
Follow-up216.0 mo
PublishedOct 2026
View Original Abstract ↓
OBJECTIVES: We aimed to evaluate the pooled prognostic accuracy of the Phoenix Sepsis Criteria (PSC) for in-hospital mortality and compare its performance with the International Pediatric Sepsis Consensus Conference (IPSCC) criteria in children with suspected infection. DATA SOURCES: PubMed, Embase, and Cochrane Central Register of Controlled Trials were searched. STUDY SELECTION: Eligible studies included prospective or retrospective studies evaluating the PSC among children younger than 18 years with suspected infection in hospital settings. DATA EXTRACTION: Two investigators independently screened, extracted study characteristics and accuracy data, and assessed quality using the Quality Assessment of Diagnostic Accuracy Studies 2 tool. DATA SYNTHESIS: A total of 15 studies (16 cohorts; 2,601,038 encounters) were included. The PSC demonstrated pooled sensitivity of 0.77 (95% CI, 0.67-0.85), specificity of 0.73 (95% CI, 0.51-0.87), diagnostic odds ratio of 9.2 (95% CI, 5.1-16.8), and area under the curve (AUC) of 0.81 (95% CI, 0.75-0.84). In contrast, the IPSCC showed lower performance (AUC, 0.71; difference, 0.10 [95% CI, 0.04-0.19]). In subgroup analyses, PSC specificity was lower in the ICU compared with the emergency department (ED) cohorts (0.48 vs. 0.99). CONCLUSIONS: The PSC demonstrates good prognostic accuracy for mortality and outperforms the IPSCC criteria. However, performance varies by setting, and the PSC is intended for prognostic risk stratification rather than frontline early sepsis screening. Further validation in the ED, ward, and lower-resource settings, as well as the development of context-specific clinical decision support tools, are warranted.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.